Search Results 241-250 of 25613 for prostate cancer
... prostate cancer. Aug. 20, 2025. Since 2022, lutetium Lu 177 vipivotide tetraxetan has been used to treat prostate-specific membrane antigen (PSMA)-positive ...
This phase II trial studies how well hypofractionated radiation therapy works in treating participants with prostate cancer high-risk features following radical ...
Examples of tumor markers include prostate-specific antigen (PSA) for prostate cancer and cancer antigen 125 (CA 125) for ovarian cancer. Other examples ...
Robotic-assisted prostatectomy has emerged as the leading approach for treating patients with prostate cancer, yet the procedures vary. While a multiport ...
Research. Doctors and scientists at Mayo Clinic are studying ways to improve proton therapy for prostate cancer. Proton therapy is an active area of cancer ...
Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer. While those findings are only preliminary, several clinical ...
68Ga-PSMA and 177Lu-PSMA are being developed as diagnostic PET imaging and therapeutic agents, respectively, in prostate cancer. As such, PSMA represents a ...
stomach, secretes enzymes to aid digestion and hormones to manage your blood sugar. Pancreatic cancer is one of the deadliest cancers, as […] The post ...
Lung cancer; Prostate cancer; Rectal cancer; Skin cancer; Soft tissue sarcomas; Vaginal cancer. Brachytherapy is most often used to treat cancer. Sometimes it's ...
Prostate cancer experts at Mayo Clinic Comprehensive Cancer Center work in ... cancer, bladder cancer and kidney cancer. Oct. 31, 2014. Bladder cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Send a note of thanks to Mayo Clinic researchers who are revolutionizing healthcare and improving patient outcomes.